Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US10722478B2 · kind B2 · utility
2Cited by
56References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2019 |
| Grant date | Jul 28, 2020 |
| Priority date | — |
| Expiry date | Aug 9, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for the treatment or prevention of fatigue associated with disordered sleep, for example, in multiple sclerosis, fibromyalgia, Fabry's disease, Parkinson's disease, or traumatic brain injury, using cyclobenzaprine. The present invention further relates to a biomarker for the therapeutic effects of a cyclobenzaprine treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.